USA Only-PSA Advocacy Opportunity-Include Your Voice

Here is a newly emerged advocacy opportunity regarding the PSA test and Prostate Cancer in the USA. Malecare feels you should be empowered to participate in this national health policy issue. CMS' Center for Medicare issued what is known as a Medicare Advantage Call letter. In the letter, the CMS signals to Medicare Advantage Plans that they will put a Healthcare Effectiveness Data and Information Set (HEDIS) "non-recommended PSA screening measure" as a display measure in 2018 and will consider it for the 2019 Star ratings. CMS is the US federal agency that administers Medicare, Medicaid, and the State Children's [...]

By | February 22nd, 2017|Advanced Prostate Cancer, Uncategorized|0 Comments

Travel & Refugee Ban Hurts Cancer Patients

All of us are affected by the recent refugee and travel ban. At one time or another, all of us have been helped by doctors, medical students, nurses, social workers, caregivers and fellow cancer patients who were born outside of the United States.  Many of the treatments and drugs that keep us alive were developed by foreign born scientists and researchers.  And, like me, some of us are partnered or married to men and women who were born outside of our borders. Barring people of a particular origin or religion from entering the U.S. is antithetical to both Malecare’s and [...]

By | January 31st, 2017|Advanced Prostate Cancer, Uncategorized|1 Comment

Did You Know That Metastatic Prostate Cancer Causes DNA Mutations?

Men with metastatic prostate cancer have higher rates of inherited gene mutations than men with non-metastatic prostate cancer.  Knowing about DNA mutations might help you make better treatment decisions. And you can also tell family members about their risk. Recent studies have shown that metastatic prostate cancer inherited mutations in the DNA-repair genes, such as the BRCA gene, can help guide treatment decisions as well as increase cancer risk in their family members. These mutations are more common in men with metastatic prostate cancer compared with men whose prostate cancer hasn’t spread outside the prostate gland. Men with advanced, metastatic prostate cancer should ask to be [...]

Being A “Cancer Hater” is Not Productive

My wife Wendy periodically receives Facebook requests for her to “Hate Cancer.” Yes, she does hate cancer, but she wants us all to actually be productive about what we do with our “hate.” Wendy wrote on Facebook,  "I'm not a cut and paster, and certainly not a "hater," so I have an alternative suggestion.  I just had the remarkable experience of visiting the National Cancer Institute at NIH, when my husband (a survivor of 5 separate unrelated cancers, including one metastatic, and one very rare) volunteered for a clinical trial. The caliber of research and commitment there (and in so many of our [...]

By | December 30th, 2016|Advanced Prostate Cancer, advocacy, Uncategorized|0 Comments